The 'Innovation Zone' at the life sciences event, organised by the Telangana government, will feature a startup stage pavilion and an incub...

Mandaviya said the union government is promoting an enabling ecosystem for innovation in the pharma-medtech sector to become a leader in dr...

The Transasia-Erba monkeypox RT-PCR kit is highly sensitive, but an easy-to-use test with uniquely formulated primer and probe for enhanced...

AMTZ is an enterprise established by the Indian Government and the Government of Andhra Pradesh to manufacture medical equipment. Aiming to...

The Mumbai-based med-tech player received the green signal from capital market's watchdog Sebi to float its Rs 6,250 crore-primary stake sa...

The Central Drugs Standard Control Organisation (CDSCO) is presently regulating 28 categories of notified medical devices under the provisi...

The Union Health Ministry on Tuesday said about 96 per cent of the 60,000 ventilators being procured by the government are indigenous and m...

The mobile lab, also called I-Lab or Infectious Diseases Diagnostics Lab, can run 50 RT-PCR and about 200 ELISA tests in a day.

While standard RT-PCR kits in the market are probe-based, this design does away with probes completely. Instead it detects COVID-19 specifi...

Naidu said schemes such as Anna Canteens, insurance and real-time governance system (RTGS) could help effectively handle the Covid-19 outbr...

The unit at AP MedTech Zone in Visakhapatnam can produce 2,000 testing kits a day, the state government said on Wednesday. This capacity ma...

The four parks will be set up in Andhra Pradesh, Telangana, Tamil Nadu and Kerala, sources said, adding that Uttarakhand and Gujarat have a...

The finding comes as the UK government announced plans to launch a new start-up visa route, which is expected to attract more such investor...

The facility, to come up on an area of 20,000 sft, will offer prototyping and low volume manufacturing to medical devices companies in AMTZ.

The public-private partnership is aimed at reducing the medical devices imports and production cost and to help deliver quality medical dev...

The price regulator will ensure that all medicines are regulated and are available at affordable rates to the public.

India's pharma sector, which has achieved a Compounded Annual Growth Rate (CAGR) of over 15%, would be worth $55 billion by 2020.